# System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony
> **Product code: PMY** · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.1640
## Classification
- **FDA Product Code:** PMY
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 866.1640
- **Review panel:** MI
- **Medical specialty:** Microbiology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

To detect the presence of genetic markers of antimicrobial resistance by testing isolated bacterial colonies using nucleic  acid amplification technology.

## Market data
- **Cleared 510(k) submissions:** 3
- **Registered establishments:** 4
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=PMY)
---
*AI Analytics · CC0 1.0*